Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune responseFDA granted EUA based on Phase... | June 21, 2023
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, March 30, 2023and on the Company's website in the Investors section). "ONWARD is committed to creating long-term value for all
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, March 30, 2023 -- ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement,... | March 30, 2023
Mainz Biomed’s proprietary nucleic acid extraction and PCR process proved to be highly effectiveTwo mRNA biomarkers found to be particularly valuable in detecting disease signals in advanced... | March 29, 2023
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous29.03.2023 / 09:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas Mai...